SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050576
Filing Date
2020-11-04
Accepted
2020-11-04 17:10:49
Documents
56
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q onct-10q_20200930.htm   iXBRL 10-Q 1797121
2 EX-31.1 onct-ex311_8.htm EX-31.1 16969
3 EX-31.2 onct-ex312_9.htm EX-31.2 16953
4 EX-32.1 onct-ex321_7.htm EX-32.1 6751
5 EX-32.2 onct-ex322_6.htm EX-32.2 6806
  Complete submission text file 0001564590-20-050576.txt   5699003

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA onct-20200930.xsd EX-101.SCH 52742
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE onct-20200930_cal.xml EX-101.CAL 31729
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE onct-20200930_def.xml EX-101.DEF 161448
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20200930_lab.xml EX-101.LAB 367626
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20200930_pre.xml EX-101.PRE 265217
11 EXTRACTED XBRL INSTANCE DOCUMENT onct-10q_20200930_htm.xml XML 768084
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50549 | Film No.: 201287533
SIC: 2834 Pharmaceutical Preparations